Veeva Rides AI Wave As Pharma Cloud Story Accelerates

Veeva Systems reports Q1 beat and raises guidance. Analysts maintain Buy ratings and see potential in AI initiatives.

Latest Ratings for VEEV

DateFirmActionFromTo Mar 2022JMP SecuritiesMaintainsMarket Outperform Mar 2022SVB LeerinkMaintainsOutperform Mar 2022B of A SecuritiesDowngradesBuyNeutral

View More Analyst Ratings for VEEV

View the Latest Analyst Ratings

Importance Rank: 
1

read more